Hypoglycemia Prevention in High-Risk Type 2 Diabetes Patients
Completed · Not applicable
Conditions studied: Diabetes
In brief
Severe low blood sugar (hypoglycemia) is a serious problem for people with diabetes. It can lead to dangerous falls, heart problems, memory issues, and even death. However, many healthcare providers don't recognize or manage this problem well. The investigators believe that creating a clear set of guidelines for preventing hypoglycemia, along with having a clinical pharmacist actively help high-risk patients, can make diabetes treatment safer. In this study, the investigators developed a simple, evidence-based guide called "Hypoglycemia on a Page" (HOAP) to prevent low blood sugars. The investigators then tested it by comparing two groups of patients with type 2 diabetes who are at high risk for hypoglycemia. One group received active support from a clinical pharmacist using the HOAP guidelines, while the other group received standard care. The main goal of this study is to see if the pharmacist's support leads to safer diabetes treatment. The investigators will also look at other factors, such as whether patients are prescribed glucagon (a medicine for severe low blood sugar), if they use continuous glucose monitoring, and whether they have worse blood sugar control or end up in the hospital for hypoglycemia. This trial aims to improve patient safety, health outcomes, and possibly lower healthcare costs.
Key facts
- Study ID
- NCT06746714
- Run by
- Kaiser Permanente
- People needed
- 200
- Starts
- 2023-07-20
- Expected to finish
- 2024-12-20
- Last updated by the study team
- 2024-12-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Active KPNC members with valid MRNs at baseline (06/01/2023),
- age >=18 years,
- in the KPNC diabetes registry,
- likely type 2 diabetes (determined using a validated algorithm
- high risk for hypoglycemia, determined using the hypoglycemia risk stratification tool developed by the investigator team
You may not qualify if…
- Dementia or impaired cognition,
- psychosis or schizophrenia diagnosis,
- end-stage renal disease,
- "no contact" preferences on file,
- no primary care physician or home facility,
- receiving care at skill nursing facilities,
- deceased,
- enrolled in concurrent pharmacy deprescribing pilots
Where it is running
- Kaiser Permanente Department of Research — Pleasanton, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.